Summary
Muscular dystrophies (MD) are a clinically and genetically heterogenous disease group. In the last few years, remarkable progress has been made in understanding the close und various relations between skeletal muscle disease and heart muscle disease. Cardiac involvement has been documented in a number of primary MDs and is even the dominant feature in some of them. The myocardium can be affected in the form of a dilated cardiomyopathy while the conduction system can be affected resulting in arrhythmias and conduction defects. Many patients with MD die because of cardiac complications like sudden cardiac death or congestive heart failure. Detailed clinical data about cardiac involvement are available for Duchenne/Becker MD, Emery-Dreifuss MD, myotonic dystrophy, and the different limb girdle MDs. Cardiac manifestations were also found in congenital MD, central core disease, proximal myotonic myopathy, and nemaline myopathy. No data about cardiac abnormalities are available in oculopharyngeal MD and rippling muscle disease. The heart of patients with primary MD should be carefully investigated because of the life-threatening events caused by cardiac complications. There is a strong need for a close collaboration between neurologists and cardiologists in order to provide optimal disease management for the affected patients.
Zusammenfassung
Die Muskeldystrophien (MD) stellen sich als eine klinisch und genetisch sehr heterogene Krankheitsgruppe dar. In den vergangenen Jahren wurde zunehmend erkannt, dass es vielfältige und enge Beziehungen zwischen Muskeldystrophien und Kardiomyopathien gibt. Eine kardiale Beteiligung ist bei vielen unterschiedlichen primären MD-Formen gefunden worden und stellt bei einigen einen dominierenden Aspekt der Erkrankung dar. Die Herzbeteiligung betrifft meist das Myokard in Form einer dilatativen Kardiomyopathie und/oder das Reizleitungssystem in Form bradykarder Rhythmusstörungen. Viele Patienten mit MD versterben aufgrund dieser Manifestationen am Pumpversagen oder am plötzlichem Herztod. Bei der Duchenne/Becker MD, der Emery-Dreifuss MD, der myotonen Dystrophie und den Gliedergürtel- MDs ist die kardiale Manifestation detailiert und umfassend beschrieben worden. Eine Herzbeteiligung ist ebenfalls gefunden worden bei der kongenitalen MD, der Central Core Disease, der proximalen myotonen Myopathie und der Nemalin-Myopathie. Bei einigen seltenen Formen wie der okulopharyngealen MD und der Rippling Muscle Disease liegen keine Erkenntnisse zur Herzbeteiligung vor. Die kardiale Diagnostik sollte eine zentrale Rolle bei der Untersuchung von Patienten mit Muskelerkrankungen spielen, da kardiale Komplikationen oft lebensbedrohend sein können. Diagnostik und Therapie von Muskeldystrophien sollten in enger Zusammenarbeit von Neurologen und Kardiologen interdisziplinär erfolgen, um eine optimale Betreuung der Patienten zu gewährleisten.
Similar content being viewed by others
References
Seidman JG, Seidman C (2001) The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 104:557–567
McNally E, Allikan M, Wheeler MT, Mislow JM, Heydemann A (2003) Cytoskeletal defects in cardiomyopathy. J Mol Cell Cardiol 35:231–241
Osterziel KJ, Scheffold T, Perrot A, Dietz R. (2001) Genetik der dilatativen Kardiomyopathie. Z Kardiol 90(7):461–469
Emery AE (1991) Population frequencies of inherited neuromuscular diseases—a world survey. Neuromusc Disord 1:19
De Visser M, Vermeulen M, Wokke JHJ (1999) Neuromusculaire ziekten. Elsevier/Bunge, Maarssen
Emery AE (2002) Muscular dystrophy into the new millennium. Neuromuscul Disord 12(4):343–349
Hoogerwaard EM, van der Wouw PA, Wilde AA, Bakker E, Ippel PF, Oosterwijk JC, Majoor-Krakauer DF, van Essen AJ, Leschot NJ, de Visser M. (1999) Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy. Neuromuscul Disord 9(5):347–351
Corrado G, Lissoni A, Beretta S, Terenghi L, Tadeo G, Foglia-Manzillo G, Tagliagambe LM, Spata M, Santarone M. (2002) Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy. Am J Cardiol 89(7):838–841
Hoogerwaard EM, de Voogt WG, Wilde AA, van der Wouw PA, Bakker E, van Ommen GJ, de Visser M (1997) Evolution of cardiac abnormalities in Becker muscular dystrophy over a 13-year period. J Neurol 244 (10):657–663
Politano L, Nigro V, Nigro G, Petretta VR, Passamano L, Papparella S, Di Somma S, Comi LI (1996) Development of Cardiomyopathy in Female Carriers Of Duchenne and Becker Muscular Dystrophies. Journal of the American Medical Association 275:1335–1338
Finsterer J, Gharehbaghi-Schnell E, Stollberger C, Fheodoroff K, Seiser A. (2001) Relation of cardiac abnormalities and CTG-repeat size in myotonic dystrophy. Clin Genet 59(5):350–355
Lazarus A, Varin J, Ounnoughene Z, Radvanyi H, Junien C, Coste J, Laforet P, Eymard B, Becane HM, Weber S, Duboc D (1999) Relationships among electrophysiological findings and clinical status, heart function, and extent of DNA mutation in myotonic dystrophy. Circulation 99(8):1041–1046
Von zur Mühlen F, Klaas C, Kreuzer H, Mall G, Giese A, Reimers CD (1998) Cardiac involvement in proximal myopathy. Heart 79:619–621
Schoser, BGH (2004) Sudden cardiac death in myotonic dystrophy type 2. Neurology 63:2402–2404
Laforet P, de Toma C, Eymard B, Becane HM, Jeanpierre M, Fardeau M, Duboc D. (1998) Cardiac involvement in genetically confirmed facioscapulohumeral muscular dystrophy. Neurology 51(5):1454–1456
Stevenson WG, Perloff JK, Weiss JN, Anderson TL (1990) Facioscapulohumeral muscular dystrophy: evidence for selective, genetic electrophysiologic cardiac involvement. J Am Coll Cardiol 15(2):292–299
van der Kooi AJ, de Voogt WG, Barth PG, Busch HF, Jennekens FG, Jongen PJ, de Visser M. (1998) The heart in limb girdle muscular dystrophy. Heart 79(1):73–77
Politano L, Nigro V, Passamano L, Petretta V, Comi LI, Papparella S, Nigro G, Rambaldi PF, Raia P, Pini A, Mora M, Giugliano MA, Esposito MG. (2001) Evaluation of cardiac and respiratory involvement in sarcoglycanopathies. Neuromuscul Disord 11(2):178–185
Becane HM, Bonne G, Varnous S, Muchir A, Ortega V, Hammouda EH, Urtizberea JA, Lavergne T, Fardeau M, Eymard B, Weber S, Schwartz K, Duboc D (2000) High incidence of sudden death with conduction system and myocardial disease due to lamins A and C gene mutation. Pacing Clin Electrophysiol 23(11 Pt 1):1661–1666
Arbustini E, Pilotto A, Repetto A, Grasso M, Negri A, Diegoli M, Campana C, Scelsi L, Baldini E, Gavazzi A, Tavazzi L (2002) Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease. J Am Coll Cardiol 39(6):981–990
Sanoudou D, Beggs AH (2001) Clinical and genetic heterogeneity in nemaline myopathy—a disease of skeletal muscle thin filaments. Trends Mol Med 8:362–368
Ishibashi-Ueda H, Imakita M, Yutani C, Takahashi S, Yazawa K, Kamiya T, Nonaka I (1990) Congenital nemaline myopathy with dilated cardiomyopathy: an autopsy study. Hum Pathol 21:77–82
Smeiting J, van den Heiwel L, di-Mauro S (2001) The genetics and pathology of oxidative phosphorylation. Nat Rev Genet 2:342–52
Anan R, Kagakawa M, Miyata M, Higuchi I, Kakao S, Suehara M, Osame M, Tanak H (1995) Cardiac involvement in mitochondrial diseases. Circulation 91:955–961
Tanaka M, Ino H, Ohno K, Hattori K, Sato W, Ozawa T (1990) Mitochondrial mutation in fatal infantile cardiomyopathy. Lancet 4:1452
Toda T, Kobayashi K, Kondo-Iida E, Sasaki J, Nakamura Y (2000) The Fukuyama congenital muscular dystrophy story. Neuromuscul Disord 10(3):153–159
Hayashi YK, Ogawa M, Tagawa K, Noguchi S, Ishihara T, Nonaka I, Arahata K (2001) Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy. Neurology 57(1):115–121
Emery AE (2000) Emery-Dreifuss muscular dystrophy—a 40 year retrospective. Neuromuscul Disord 10(4-5):228–232
Bione S, Maestrini E, Rivella S, Mancini M, Regis S, Romeo G, Toniolo D (1994) Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy. Nat Genet 8(4):323–327
Bonne G, Di Barletta MR, Varnous S, Becane HM, Hammouda EH, Merlini L, Muntoni F, Greenberg CR, Gary F, Urtizberea JA, Duboc D, Fardeau M, Toniolo D, Schwartz K (1999) Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet 21:285–288
Buckley AE, Dean J, Mahy IR (1999) Cardiac involvement in Emery Dreifuss muscular dystrophy: a case series. Heart 82:105–108
Fatkin D, MacRae C, Sasaki T, Wolff MR, Porcu M, Frenneaux M, Atherton J, Vidaillet HJ, Jr, Spudich S, De Girolami U, Seidman JG, Seidman CE, Muntoni F, Muehle G, Johnson W, McDonough B (1999) Missense Mutations in the Rod Domain of the Lamin A/C Gene as Causes of Dilated Cardiomyopathy and Conduction-System Disease. New England Journal of Medicine 341:1715–1724
Sjoberg G, Saavedra Matiz CA, Rosen DR, Wijsman EM, Borg K, Horowitz SH, Sejersen T (1999) A missense mutation in the desmin rod domain is associated with autosomal dominant distal myopathy, and exerts a dominant negative effect on filament formation. Hum Mol Genet 8:2191–2198
Dalakas MC, Park KY, Semino Mora C, Lee HS, Sivakumar K, Goldfarb LG. (2000) Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. New England Journal of Medicine 342:770–780
Hackenberg T (1992) Heart transplantation in a patient with central core disease. J Cardiothorac Vasc Anaesth 6:386–387
Fananapazir L, Dalakas MC, Cyran F, Cohn G, Epstein ND (1993) Missense mutations in the b-myosin heavy chain gene cause central core disease in hypertrophic cardiomyopathy. Proc Natl Acad Sci USA 90:3993–3997
Becher MW, Morrison L, Davis LE, Maki WC, King MK, Bicknell JM, Reinert BL, Bartolo C, Bear DG (2001) Oculopharyngeal muscular dystrophy in Hispanic New Mexicans. JAMA 286(19):2437–2440
Betz RC, Schoser BG, Kasper D, Ricker K, Ramirez A, Stein V, Torbergsen T, Lee YA, Nothen MM, Wienker TF, Malin JP, Propping P, Reis A, Mortier W, Jentsch TJ, Vorgerd M, Kubisch C (2001) Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease. Nat Genet 28(3):218–219
Hoppe UC, Erdmann E (2001) Leitlinien zur Therapie der chronischen Herzinsuffizienz. Z Kardiol 90:218–237
Himmrich E, Popov S, Liebrich A, Rosocha S, Zellerhoff C, Nowak B, Przibille O (2000) Verborgene intrakardiale Leitungsstörungen und deren spontaner Verlauf bei Patienten mit progressiver Muskeldystrophie. Z Kardiol 89:592–598
Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, Naccarelli GV, Schoenfeld MH, Silka MJ, Winters SL (2002) ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines) Circulation 106:2145–2161
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Perrot, A., Spuler, S., Geier, C. et al. Kardiale Manifestationen bei Muskeldystrophien. ZS Kardiologie 94, 312–320 (2005). https://doi.org/10.1007/s00392-005-0232-3
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00392-005-0232-3